0.25% Bupivacaine Hcl Injection, Solution
Product Images NDC 51662-1606

22 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for 0.25% Bupivacaine Hcl (NDC 51662-1606). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Boxed Warning (Warnings)

Boxed Warning (Warnings)
A text panel discussing the risks associated with the 0.75% concentration of bupivacaine hydrochloride. It notes that this concentration is not recommended for obstetrical anesthesia due to reports of cardiac arrest and difficult resuscitation. The panel advises that the 0.75% concentration should be reserved for surgical procedures requiring a high degree of muscle relaxation and prolonged effect.*
FDA Label Image
FDA Label Image

Structure 1 (Structure 1)

Structure 1 (Structure 1)
Chemical structure diagram of 0.25% BUPIVACAINE HCl showing the molecular components including a piperidine ring, an amide linkage, a substituted aromatic ring with two methyl groups, and hydration and hydrochloride components.*
FDA Label Image

Structure 2 (Structure 2)

Structure 2 (Structure 2)
Chemical structure of 0.25% Bupivacaine HCl shown as a molecular diagram with functional groups and bonds depicted.*
FDA Label Image

Description 1 (Description 1)

Description 1 (Description 1)
A table showing concentration levels of Bupivacaine Hydrochloride and Sodium Chloride. Concentrations include 0.25%, 0.50%, and 0.75%, with corresponding Bupivacaine Hydrochloride amounts of 2.5, 5, and 7.5 mg/mL, and Sodium Chloride amounts of 8.6, 8.1, and 7.6 mg/mL respectively.*
FDA Label Image

Description 2 (Description 2)

Description 2 (Description 2)
A data table showing concentrations of Bupivacaine HCl in three formulations: 0.25%, 0.50%, and 0.75%. It lists corresponding Bupivacaine Hydrochloride amounts in mg/mL (2.5, 5, 7.5), Epinephrine 1:200,000 concentration in mcg/mL (5 for all), and Sodium Chloride concentration in mg/mL (8.5 for all).*
FDA Label Image

Indications And Usage (Indications And Usage)

Indications And Usage (Indications And Usage)
A data table listing various uses of Bupivacaine HCl with corresponding concentration percentages. It includes local infiltration at 0.25%, peripheral nerve block at 0.25% and 0.5%, retrobulbar block at 0.75%, sympathetic block at 0.25%, lumbar epidural at 0.25%, 0.5%, and 0.75% (with a note that 0.75% is not for obstetrical anesthesia), caudal at 0.25% and 0.5%, epidural test dose at 0.5% with epinephrine 1:200,000, and dental blocks at 0.5% with epinephrine 1:200,000.*
FDA Label Image

Precautions (Precautions)

Precautions (Precautions)
A data table listing drug classes and examples, including Nitrates/Nitrites (e.g., nitric oxide, nitroglycerin), Local anesthetics (e.g., bupivacaine, lidocaine), Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with corresponding examples in each class.*
FDA Label Image

Dosage And Administration (Dosage And Administration)

Dosage And Administration (Dosage And Administration)
A data table showing dosage information per type of nerve block for Bupivacaine HCl injections. It lists block types like local infiltration, epidural, caudal, peripheral nerves, retrobulbar, sympathetic, dental, and epidural test dose, with corresponding concentrations, dose volumes, mg amounts, and motor block effects.*
FDA Label Image

How Supplied 1 (How Supplied 1)

How Supplied 1 (How Supplied 1)
A data table presenting various units of sale and concentration details for BUPIVACAINE HCl injection, solution. The table lists NDC codes, vial types (single-dose Teartop and multiple-dose Fliptop vials), vial counts of 25 per tray, concentration percentages ranging from 0.25% to 0.75%, and specific drug amounts per vial volume along with pH ranges of 4.0 to 6.5 for each formulation.*
FDA Label Image

How Supplied 2 (How Supplied 2)

How Supplied 2 (How Supplied 2)
A data table listing the unit of sale and concentration details for 0.25% and 0.50% BUPIVACAINE HCl injection solutions. It includes NDC numbers, packaging configurations such as cartons and trays of single-dose teartop vials, and cases of multiple-dose fliptop vials, along with strength in mg/mL and pH range of 3.3 to 5.5.*
FDA Label Image
FDA Label Image

Vial Label (Vial Label)

Vial Label (Vial Label)
Label for 0.5% Bupivacaine Hydrochloride Injection, USP, a multiple-dose fliptop vial containing 250 mg/50 mL (5 mg/mL). The label highlights use for nerve block and indicates it is not for caudal, epidural, or spinal anesthesia. Distributed by Hospira, Inc., Lake Forest, IL. The label includes drug content, preservatives, storage conditions, and lot/expiration placeholders.*
FDA Label Image

Rfid Label (51662 1396 1 Rfid)

Rfid Label (51662 1396 1 Rfid)
A label featuring GS1 barcode numbers, a 2D barcode on the right, and text stating "SEE MANUFACTURE'S INSERT" with distributor information: HF Acquisitions Co., LLC, Mukilteo, WA 98275. The label also includes a lot number "HF1234TESTING". This label is for 0.25% BUPIVACAINE HCl injection solution by HF Acquisition Co LLC, DBA HealthFirst.*
FDA Label Image

Pouch Labeling (51662139622 Bupivacaine Pouch Label)

Pouch Labeling (51662139622 Bupivacaine Pouch Label)
Label for 0.5% Bupivacaine Hydrochloride Injection, USP, showing strength 250 mg/50 mL (5 mg/mL) in a 50 mL vial. The label includes the NDC number 51662-1396-2, lot number 12345, and expiration date 2001-03-01. Manufactured by HF Acquisition Co., LLC, Mukilteo, WA.*
FDA Label Image

Rfid Label (51662 1396 3 Rfid)

Rfid Label (51662 1396 3 Rfid)
This image shows a portion of a packaging label for 0.25% Bupivacaine HCl injection solution. The label includes a data matrix barcode and various numeric codes. It references the distributor, HF Acquisition Co LLC, located in Mukilteo, WA 98275, and instructs to see the manufacturer's insert for more information.*
FDA Label Image

Case Labeling (51662139639 Bupivacaine Case Label)

Case Labeling (51662139639 Bupivacaine Case Label)
Label for 0.5% Bupivacaine Hydrochloride Injection, 5 mg/mL strength in a 50 mL vial, box of 25. Includes NDC 51662-1396-3, lot number 12345, and expiration date January 1, 2030. Manufactured by HF Acquisition Co LLC, Mukilteo, WA, for human prescription use.*
FDA Label Image

Pouch Labeling Updated July 2021 (51662 1396 2 Pouch Labeling)

Pouch Labeling Updated July 2021 (51662 1396 2 Pouch Labeling)
Label for 0.5% Bupivacaine Hydrochloride Injection, USP 250 mg/50 mL (5 mg/mL) in a 50 mL vial. The label includes the NDC number 51662-1396-2, lot number 123456, and expiration date 2025-01-01. It indicates the product is manufactured by HF Acquisition Co., LLC in Mukilteo, WA, and is for nerve block use only. Storage instructions and aseptic technique reminders are also included.*
FDA Label Image

Vial Label Pouch (Vial)

Vial Label Pouch (Vial)
Label of a 50 mL multiple-dose fliptop vial of 0.25% Bupivacaine Hydrochloride Injection, USP, showing a total strength of 125 mg per 50 mL (2.5 mg/mL). The label indicates use for infiltration and nerve block, with a warning against caudal, epidural, or spinal anesthesia. It includes dosage details, preservatives, storage instructions, and distributor information for Hospira, Inc.*
FDA Label Image

Pouch Label (51662 1606 2 Pouch Label)

Pouch Label (51662 1606 2 Pouch Label)
Text panel for 0.25% Bupivacaine HCl Injection, USP, 125 mg/50 mL (2.5 mg/mL) in a 50 mL vial. Includes NDC number 51662-1606-2, lot number, and expiration date. Provides drug composition per mL, preservative details, storage conditions at 20 to 25°C, and administration notes specifying infiltration and nerve block use only. Manufactured by HF Acquisition Co., LLC.*
FDA Label Image

Serialized Label (51662 1606 3 Serialized Label)

Serialized Label (51662 1606 3 Serialized Label)
Partial view of a white label on pharmaceutical packaging with black printed text including numerical codes and a small QR code identification. The label instructs to see manufacturer's insert and mentions distribution by HF Acquisitions Co., LLC, Mukilteo, WA 98275. The image does not show the full product name or details.*
FDA Label Image

Case Label (51662 1606 3 Case Label)

Case Label (51662 1606 3 Case Label)
0.25% Bupivacaine HCl Injection, USP, 125 mg/50 mL (2.5 mg/mL) solution in a 50 mL vial. The label states it is for infiltration and nerve block, not for caudal, epidural, or spinal anesthesia. Manufactured by HF Acquisition Co, LLC, Mukilteo, WA. The lot number, expiration date, and NDC 51662-1606-3 are shown. Storage instructions and preservative information are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.